267 related articles for article (PubMed ID: 21839245)
1. Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine.
Castel MA; Farrero M; Vallejos I; Cardona M; Regueiro A; Pérez-Villa F
Transplant Proc; 2011; 43(6):2244-6. PubMed ID: 21839245
[TBL] [Abstract][Full Text] [Related]
2. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
[TBL] [Abstract][Full Text] [Related]
3. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
Pliszczynski J; Kahan BD
Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
5. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
6. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
Kobashigawa JA; Patel J; Furukawa H; Moriguchi JD; Yeatman L; Takemoto S; Marquez A; Shaw J; Oeser BT; Subherwal S; Wu GW; Kawano J; Laks H
J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
[TBL] [Abstract][Full Text] [Related]
7. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine versus tacrolimus maintenance therapy in renal transplant.
Alghamdi S; Nabi Z; Skolnik E; Alkorbi L; Albaqumi M
Exp Clin Transplant; 2011 Jun; 9(3):170-4. PubMed ID: 21649564
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus.
Fuchs U; Zittermann A; Ensminger SM; Schulz U; Gummert JF
Transpl Immunol; 2014 Aug; 31(2):87-91. PubMed ID: 24932812
[TBL] [Abstract][Full Text] [Related]
10. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
[TBL] [Abstract][Full Text] [Related]
11. Spousal versus living unrelated renal transplantation: a retrospective analysis of allograft outcomes.
Solak I; Sezer TO; Toz H; Tatar E; Isayev C; Firat O; Hoscoskun C
Transplant Proc; 2012; 44(6):1710-2. PubMed ID: 22841250
[TBL] [Abstract][Full Text] [Related]
12. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
Opelz G; Döhler B;
Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
[TBL] [Abstract][Full Text] [Related]
13. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
[TBL] [Abstract][Full Text] [Related]
14. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
Krämer BK; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Ortuño J; Sester U; Kunzendorf U; Dietl KH; Bonomini V; Rigotti P; Ronco C; Tabernero JM; Rivero M; Banas B; Mühlbacher F; Arias M; Montagnino G;
Nephrol Dial Transplant; 2008 Jul; 23(7):2386-92. PubMed ID: 18258740
[TBL] [Abstract][Full Text] [Related]
16. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
Watt KD; Dierkhising R; Heimbach JK; Charlton MR
Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.
Trompeter R; Filler G; Webb NJ; Watson AR; Milford DV; Tyden G; Grenda R; Janda J; Hughes D; Ehrich JH; Klare B; Zacchello G; Bjorn Brekke I; McGraw M; Perner F; Ghio L; Balzar E; Friman S; Gusmano R; Stolpe J
Pediatr Nephrol; 2002 Mar; 17(3):141-9. PubMed ID: 11956848
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center.
Foroncewicz B; Mucha K; Ryszkowska E; Ciszek M; Ziółkowski J; Porowski D; Krawczyk M; Paczek L
Transplant Proc; 2009 Oct; 41(8):3103-6. PubMed ID: 19857686
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.
Cholongitas E; Shusang V; Germani G; Tsochatzis E; Raimondo ML; Marelli L; Senzolo M; Davidson BR; Patch D; Rolles K; Burroughs AK
Clin Transplant; 2011; 25(4):614-24. PubMed ID: 20718824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
